EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Effects of vitamin d replacement combined with Graves’ disease therapy: a retrospective cohort study

Beyza Taşkent Sezgin iD, Muhammed Kizilgül iD, Özgür Özçelik iD, Taner Demirci iD, Hayri Bostan iD, Ümran Gül iD, Bekir Uçan iD

Turkish Journal of Medical Sciences · 18.02.2025 · 55 (1) · 87-95

DOI: 10.55730/1300-0144.5946 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 18.02.2025. Verfasst von Beyza Taşkent Sezgin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Ermenek State Hospital, Karaman, Turkiye. Hauptthemen laut MEDLINE: Graves Disease, Vitamin D, Antithyroid Agents, Vitamin D Deficiency. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/aim: In Graves’ disease (GD), an autoimmune disease, antibodies targeting the TSH receptor cause the production of excessive amounts of thyroid hormone. A significant association has been reported between low 25(OH) Vitamin D3 (VitD) levels and various autoimmune disorders. Therefore, this study aimed to investigate the effects of VitD deficiency and replacement therapy on laboratory and clinical parameters in GD patients.Methods:Fourty GD and 37 healthy control patients were included in this study. Patients with GD were divided into two groups, and the first group was given only antithyroid treatment (n:18), and the second group was given antithyroid treatment plus VitD replacement (n:22). Clinical and laboratory data of all participants were compared at the time of diagnosis and 3 months after treatment.Results: Baseline serum VitD levels in patients with GD were significantly lower than the baseline serum VitD levels of the control group (16.1±9.9 ng/ml vs 22.2±8.5 ng/ml, p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graves DiseaseVitamin DAntithyroid AgentsVitamin D DeficiencyHumansFemaleMaleAdultRetrospective StudiesMiddle AgedHormone Replacement Therapy

Stichwörter der Autor:innen

Graves’ diseaseTSH receptor antibodyvitamin D replacement

Substanzen

Vitamin DAntithyroid Agents

Autor:innen und Institutionen

  • Department of Internal Medicine, Ermenek State Hospital, Karaman, Turkiye.
  • Department of Endocrinology and Metabolism, Ankara Etlik City Hospital, Ankara, Turkiye.
  • Department of Endocrinology and Metabolism, Sakarya University Research and Education Hospital, Sakarya, Turkiye.
  • Department of Endocrinology and Metabolism, Çanakkale Mehmet Akif Ersoy State Hospital, Çanakkale, Turkiye.

ORCID-Profile: Beyza Taşkent Sezgin, Muhammed Kizilgül, Özgür Özçelik, Taner Demirci, Hayri Bostan, Ümran Gül, Bekir Uçan

Zitieren

APA

Taşkent Sezgin, B., Kizilgül, M., Özçelik, Ö., Demirci, T., Bostan, H., Gül, Ü., & Uçan, B. (2025). Effects of vitamin d replacement combined with Graves’ disease therapy: a retrospective cohort study. Turkish Journal of Medical Sciences, 55(1), 87-95. https://doi.org/10.55730/1300-0144.5946

Vancouver

Taşkent Sezgin B, Kizilgül M, Özçelik Ö, Demirci T, Bostan H, Gül Ü, et al. Effects of vitamin d replacement combined with Graves’ disease therapy: a retrospective cohort study. Turkish Journal of Medical Sciences. 2025;55(1):87-95. doi:10.55730/1300-0144.5946

BibTeX
@article{TakentSezgin2025,
  author = {Taşkent Sezgin, Beyza and Kizilgül, Muhammed and Özçelik, Özgür and Demirci, Taner and Bostan, Hayri and Gül, Ümran and Uçan, Bekir},
  title = {Effects of vitamin d replacement combined with Graves’ disease therapy: a retrospective cohort study},
  journal = {Turkish Journal of Medical Sciences},
  year = {2025},
  volume = {55},
  number = {1},
  pages = {87--95},
  doi = {10.55730/1300-0144.5946}
}
Kostenlos starten →